Overview
Arima Genomics provides Hi-C technology and end-to-end solutions for 3D genomic analysis, enabling discovery of biomarkers and therapies in human health, cancer diagnostics, and epigenetics. Their assays capture long-range chromatin interactions, including compartments, TADs, and loops, with user-friendly workflows compatible with standard NGS protocols and low-input DNA options. Partnerships like with Fox Chase Cancer Center integrate their Aventa tests into clinical protocols for lymphoma and sarcoma.
Frequently asked questions
- What Hi-C technologies does Arima Genomics offer for pharma R&D?
- Arima offers robust Hi-C kits and workflows for genome-wide or targeted 3D genomics, including Arima-HiC, single-cell 3C kits, and Aventa tests for cancer diagnostics, with flexible sample requirements and integration with NGS.
- What are the key applications in human health and cancer?
- Applications focus on redefining cancer diagnostics via whole-genome 3D structure, improving chromatin loop detection, and enabling therapy selection insights, as used in partnerships with Fox Chase for lymphoma and sarcoma testing.
- What are the workflow capabilities and timelines?
- Workflows are user-friendly, taking as little as 6 hours from sample to discovery, with end-to-end solutions, low sequencing depths, and compatibility across organisms for epigenetics and structural variation studies.